(Q82698020)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027484%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Age-related macular degeneration (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027484%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

4

Emily Y Chew

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027484%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

2

Chi-Chao Chan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027484%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Hanna R Coleman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027484%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Frederick L Ferris

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027484%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

1 November 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027484%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027484%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

372

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027484%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

1835-1845

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027484%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

9652

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027484%20AND%20SRC:MED&resulttype=core&format=json

Causes and prevalence of visual impairment among adults in the United States

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

The prevalence of age-related maculopathy in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Age-specific causes of bilateral visual impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

A simplified severity scale for age-related macular degeneration: AREDS Report No. 18

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Age-Related Macular Degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Current concepts in the pathogenesis of age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Pathogenesis of lesions in late age-related macular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Causes of blind certifications in England and Wales: April 1999–March 2000

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Risk factors for age-related macular degeneration: Pooled findings from three continents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Age-specific prevalence and causes of bilateral and unilateral visual impairment in older Australians: the Blue Mountains Eye Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Fifteen-Year Cumulative Incidence of Age-Related Macular Degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Five-year incidence of age-related maculopathy: the Visual Impairment Project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Prevalence of age-related maculopathy. The Beaver Dam Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

The prevalence of age-related maculopathy by geographic region and ethnicity. The Colorado-Wisconsin Study of Age-Related Maculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

The Grading and Prevalence of Macular Degeneration in Chesapeake Bay Watermen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

The prevalence of age-related maculopathy: the visual impairment project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liées à l'Age.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Senile macular degeneration: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Risk factors for age-related maculopathy: the Visual Impairment Project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Smoking and age-related maculopathy. The Blue Mountains Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

A prospective study of cigarette smoking and risk of age-related macular degeneration in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Case-control study of the risk factors for age related macular degeneration. France-DMLA Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Features of age-related macular degeneration in a black population. The Barbados Eye Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

The genetics of age-related macular degeneration: a review of progress to date

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Genetic risk of age-related maculopathy. Population-based familial aggregation study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Familial aggregation of age-related maculopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Family history and age-related maculopathy: the Blue Mountains Eye Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Heredity and age-related macular degeneration. Observations in monozygotic twins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

A twin study of age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Complement factor H polymorphism in age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Complement factor H polymorphism and age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Complement factor H variant increases the risk of age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Association of the Y402H polymorphism in complement factor H gene and neovascular age-related macular degeneration in Chinese patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Complement C3 variant and the risk of age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Susceptibility genes for age-related maculopathy on chromosome 10q26

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

HTRA1 promoter polymorphism in wet age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samples

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

The LOC387715 gene, smoking, body mass index, environmental associations with advanced age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Risk factors for incident age-related macular degeneration: pooled findings from 3 continents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Dietary fat and age-related maculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Prospective study of dietary fat and the risk of age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Relationship of dietary fat to age-related maculopathy in the Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Dietary fat and risk for advanced age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Cardiovascular risk factors and age-related macular degeneration: the Los Angeles Latino Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Neovascular age-related macular degeneration and its relationship to antioxidant intake

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Dietary antioxidant intake and incidence of early age-related maculopathy: the Blue Mountains Eye Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Does dietary lutein and zeaxanthin increase the risk of age related macular degeneration? The Melbourne Visual Impairment Project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Dietary intake of antioxidants and risk of age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Vitamin E supplementation and macular degeneration: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Lutein, zeaxanthin, and the macular pigment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Antioxidant status and neovascular age-related macular degeneration. Eye Disease Case-Control Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

The Relationship of Dietary Carotenoid and Vitamin A, E, and C Intake With Age-Related Macular Degeneration in a Case-Control Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Association of zinc and antioxidant nutrients with age-related maculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

The Relationship of Dietary Lipid Intake and Age-Related Macular Degeneration in a Case-Control Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Dietary fatty acids and the 5-year incidence of age-related maculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

The relationship of ocular factors to the incidence and progression of age-related maculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

The long-term effects of visible light on the eye.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Light exposure and the risk of age-related macular degeneration: the Pathologies Oculaires Liées à l'Age (POLA) study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Relationship of Basal laminar deposit and membranous debris to the clinical presentation of early age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease

2 references

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

12 December 2020

Characterization of drusen-associated glycoconjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Morphometric analysis of the macula in eyes with geographic atrophy due to age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

RPE lipofuscin and its role in retinal pathobiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

A2E: a component of ocular lipofuscin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

A2E, a byproduct of the visual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Correlation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Morphology of early choroidal neovascularisation in age-related macular degeneration: correlation with activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Morphometric analysis of the macula in eyes with disciform age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Granulomatous reaction to Bruch's membrane in age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Immunological and aetiological aspects of macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

A role for local inflammation in the formation of drusen in the aging eye.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Overstaying their welcome: defective CX3CR1 microglia eyed in macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

HtrA1 serine protease inhibits signaling mediated by Tgfbeta family proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Vitamin E and the age-related eye disease study supplementation for age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Laser treatment in patients with bilateral large drusen: the complications of age-related macular degeneration prevention trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Prophylactic laser treatment hastens choroidal neovascularization in unilateral age-related maculopathy: final results of the drusen laser study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Prophylactic treatment of age-related macular degeneration report number 1: 810-nanometer laser to eyes with drusen. Unilaterally eligible patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Pegaptanib for neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Ranibizumab for neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

The price of sight--ranibizumab, bevacizumab, and the treatment of macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961759-6

7 January 2021

Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration

1 reference

12 December 2020

A prospective study of cigarette smoking and age-related macular degeneration in women

1 reference

12 December 2020

Complement factor H polymorphisms in Japanese population with age-related macular degeneration

1 reference

12 December 2020

Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population

1 reference

12 December 2020

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

1 reference

12 December 2020

Sunlight and the 5-year incidence of early age-related maculopathy: the beaver dam eye study.

1 reference

12 December 2020

An update on the genetics of age-related macular degeneration.

1 reference

12 December 2020

Antioxidant supplements and mortality

1 reference

12 December 2020

Antioxidant supplements and mortality

1 reference

12 December 2020

Smoking and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.

1 reference

12 December 2020

Human HtrA1 in the archived eyes with age-related macular degeneration

1 reference

12 December 2020

Risk factor analysis for atrophic and exudative age-related macular degeneration. An epidemiological study of 1000 aged individuals

1 reference

12 December 2020

Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group

1 reference

12 December 2020

Quantifying changes in RPE and choroidal vasculature in eyes with age-related macular degeneration

1 reference

12 December 2020

Choroidal neovascular membranes--their visualization and treatment.

1 reference

12 December 2020

Senile macular degeneration: a histopathologic study

1 reference

12 December 2020

Argon laser photocoagulation for senile macular degeneration. Results of a randomized clinical trial

1 reference

12 December 2020

Argon laser photocoagulation for neovascular maculopathy. Three-year results from randomized clinical trials. Macular Photocoagulation Study Group

1 reference

12 December 2020

Histopathology of age-related macular degeneration

1 reference

12 December 2020

Changes in choriocapillaris and retinal pigment epithelium in age-related macular degeneration.

1 reference

12 December 2020

10.1016/S0140-6736(08)61759-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027484%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027484%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference